home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.560 +0.120 (+2.70%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 03, 2023

Via Benzinga

Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023

From Cytek Biosciences, Inc.

Via GlobeNewswire

Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

February 28, 2023

From Cytek Biosciences, Inc.

Via GlobeNewswire

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin ↗

February 14, 2023

Via Benzinga

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

February 13, 2023

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 07, 2023

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences Earnings Perspective: Return On Capital Employed ↗

December 15, 2022

Via Benzinga

Recap: Cytek Biosciences Q2 Earnings ↗

August 10, 2022

Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Preview: Cytek Biosciences ↗

August 09, 2022

Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

Via Benzinga

Where Cytek Biosciences Stands With Analysts ↗

July 14, 2022

Cytek Biosciences (NASDAQ:CTKB) has observed the following analyst ratings within the last quarter:

Via Benzinga

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

February 07, 2023

New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

February 06, 2023

From Cytek Biosciences, Inc.

Via GlobeNewswire

Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

January 10, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗

December 15, 2022

The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference

November 21, 2022

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Biosciences Introduces Cytek Cloud

November 15, 2022

New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences Reports Third Quarter 2022 Financial Results

November 09, 2022

From Cytek Biosciences, Inc.

Via GlobeNewswire

Earnings Outlook For Cytek Biosciences ↗

November 08, 2022

Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek...

Via Benzinga

Cytek® Biosciences Names Chris Williams Chief Operating Officer

October 31, 2022

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022

October 26, 2022

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference

October 26, 2022

From Cytek Biosciences, Inc.

Via GlobeNewswire

Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 06, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know ↗

August 18, 2022

Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...

Via Benzinga

Analyst Ratings for Cytek Biosciences ↗

August 12, 2022

Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Analyst Ratings for Cytek Biosciences ↗

May 13, 2022

Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know ↗

May 12, 2022

Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 21, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com